Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review / Subham Das, Saleem Akbar, Bahar Ahmed, Rikeshwar Prasad Dewangan, Mohammad Kashif Iqubal, Ashif Iqubal, Pooja Chawla, Faheem Hyder Pottoo, Alex Joseph
As a source of therapeutic agents, heterocyclic nitrogen-containing compounds and their derivatives are still interesting and essential. Pyrazole, a five-member heteroaromatic ring with two nitrogen atoms, has a major impact in chemical industries as well as pharmaceutical industries. Due to its wide range of biological activities against various diseases, it has been identified as a biologically important heterocyclic scaffold. The treatment of neurological disorders has always been a difficult task in both the past and present. Therefore, identifying therapeutically effective molecules for neurological conditions remains an open challenge in biomedical research and development. For developing novel entities as neuroprotective agents, recently, pyrazole scaffold has attracted medicinal chemists worldwide. The major focus of research in this area is discovering novel molecules as neuroprotective agents with minimal adverse effects and better effectiveness in improving the neurological condition. This review mainly covers recent developments in the neuropharmacological role of pyrazole incorporated compounds, including their structural-activity relationship (SAR), which also further includes IC 50 values (in mM as well as in μM), recent patents, and a brief history as neuroprotective agents.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
CNS & neurological disorders, drug targets - 21(2023), 10, Seite 12 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Das, Subham [VerfasserIn] |
---|
Links: |
FID Access [lizenzpflichtig] |
---|
Umfang: |
1 Online-Ressource (12 p) |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
KFL011169141 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | KFL011169141 | ||
003 | DE-627 | ||
005 | 20231128075641.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230613s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)KFL011169141 | ||
035 | |a (KFL)prod_DARH_.44EA91345B8A96E4CD1A910F896CA998BD2BD9D6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
084 | |a PHARM |q DE-84 |2 fid | ||
100 | 1 | |a Das, Subham |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review |c Subham Das, Saleem Akbar, Bahar Ahmed, Rikeshwar Prasad Dewangan, Mohammad Kashif Iqubal, Ashif Iqubal, Pooja Chawla, Faheem Hyder Pottoo, Alex Joseph |
264 | 1 | |c 2023 | |
300 | |a 1 Online-Ressource (12 p) | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a As a source of therapeutic agents, heterocyclic nitrogen-containing compounds and their derivatives are still interesting and essential. Pyrazole, a five-member heteroaromatic ring with two nitrogen atoms, has a major impact in chemical industries as well as pharmaceutical industries. Due to its wide range of biological activities against various diseases, it has been identified as a biologically important heterocyclic scaffold. The treatment of neurological disorders has always been a difficult task in both the past and present. Therefore, identifying therapeutically effective molecules for neurological conditions remains an open challenge in biomedical research and development. For developing novel entities as neuroprotective agents, recently, pyrazole scaffold has attracted medicinal chemists worldwide. The major focus of research in this area is discovering novel molecules as neuroprotective agents with minimal adverse effects and better effectiveness in improving the neurological condition. This review mainly covers recent developments in the neuropharmacological role of pyrazole incorporated compounds, including their structural-activity relationship (SAR), which also further includes IC 50 values (in mM as well as in μM), recent patents, and a brief history as neuroprotective agents | ||
700 | 1 | |a Akbar, Saleem |e verfasserin |4 aut | |
700 | 1 | |a Ahmed, Bahar |e verfasserin |4 aut | |
700 | 1 | |a Dewangan, Rikeshwar Prasad |e verfasserin |4 aut | |
700 | 1 | |a Iqubal, Mohammad Kashif |e verfasserin |4 aut | |
700 | 1 | |a Iqubal, Ashif |e verfasserin |4 aut | |
700 | 1 | |a Chawla, Pooja |e verfasserin |4 aut | |
700 | 1 | |a Pottoo, Faheem Hyder |e verfasserin |4 aut | |
700 | 1 | |a Joseph, Alex |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t CNS & neurological disorders, drug targets |d Saif Zone, Sharjah, U.A.E. : [Verlag nicht ermittelbar], 2006 |g 21(2023), 10, Seite 12 |h Online-Ressource |w (DE-627)KFL000006513 |w (DE-600)2254204-8 |w (DE-576)273891022 |x 1996-3181 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2023 |g number:10 |g pages:12 |
856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/bentham-ejournals-pharmazie/www.eurekaselect.com/openurl/content.php?genre=article&issn=1871-5273&volume=21&issue=10&spage=940 |m X:KFL |x Verlag |y FID Access |z lizenzpflichtig |
912 | |a ZDB-1-BEJ | ||
912 | |a GBV_KFL | ||
912 | |a FID-PHARM | ||
935 | |i IMPORT_0628_prod_DARH_03 | ||
951 | |a AR | ||
952 | |d 21 |j 2023 |e 10 |h 12 |